Cargando...
Hyperbaric Oxygen Preconditioning Provides Preliminary Protection Against Doxorubicin Cardiotoxicity
BACKGROUND: Doxorubicin (DOX) is generally recognized to have important cardiotoxic side effects. Studies are contradictory about the interaction between hyperbaric oxygen (HBO(2)) therapy and doxorubicin-induced cardiomyotoxicity. Recent data suggests that HBO(2) therapy can lead to preconditioning...
Gardado en:
| Publicado en: | Acta Cardiol Sin |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taiwan Society of Cardiology
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5364156/ https://ncbi.nlm.nih.gov/pubmed/28344418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS20160404B |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|